Venerable, family-owned store filling prescriptions & carrying an eclectic range of gift items.

During the past decade, Ostrom Drugs conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ostrom Drugs" are "Analgesia" (1 trials), "Frequent Heartburn" (1 trials), "Hypercholesterolemia" (1 trials) and "Patient Compliance" (1 trials). Many other conditions were trialed in "Ostrom Drugs" in a lesser frequency.

Most popular intervention types in "Ostrom Drugs" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin calcium 10 mg" (1 trials), "Ibuprofen 400 mg caplet" (1 trials), "Ibuprofen 600 mg Immediate Release/Extended Release Caplet" (1 trials) and "Rabeprazole sodium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ostrom Drugs" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ostrom Drugs". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ostrom Drugs, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ostrom Drugs, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".